Valuation: Novartis AG

Market Cap 266B 238B 221B 201B 379B 25,654B 382B 2,675B 1,041B 13,094B 1T 978B 42,088B P/E 2026 *
19.7x
P/E 2027 * 16.6x
Enterprise Value 298B 266B 247B 225B 424B 28,679B 427B 2,991B 1,164B 14,637B 1,118B 1,094B 47,049B EV / Sales 2026 *
5.16x
EV / Sales 2027 * 4.8x
Free-Float
91.66%
Yield 2026 *
3.1%
Yield 2027 * 3.23%
Manager TitleAgeSince
Chief Executive Officer 50 2018-01-31
Director of Finance/CFO - 2026-03-15
Compliance Officer 58 2025-04-13
Director TitleAgeSince
Director/Board Member 67 2014-12-31
Director/Board Member 69 2015-12-31
Director/Board Member 61 2015-12-31
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 267B
+0.02%-3.52%+35.27%+111.11% 1,019B
-1.21%-6.99%+34.42%+60.96% 617B
+1.12%-0.20%+15.45%+80.24% 464B
-3.30%-6.15%+57.14%+34.69% 356B
+0.93%-3.16%+21.65%+43.02% 333B
+0.12%-2.77%+10.70%+32.97% 267B
-0.89%-6.28%-7.00%+8.01% 244B
-0.01%-3.62%+37.01%+52.02% 218B
-0.08%-4.98%+27.34%+93.61% 179B
Average -0.70%-3.54%+25.78%+57.40% 410.8B
Weighted average by Cap. -0.50%-3.54%+28.68%+68.60%

Financials

2026 *2027 *
Net sales 57.7B 51.47B 47.95B 43.64B 82.18B 5,557B 82.79B 579B 225B 2,836B 217B 212B 9,116B 61.42B 54.79B 51.05B 46.45B 87.48B 5,915B 88.13B 617B 240B 3,019B 231B 226B 9,704B
Net income 14.26B 12.72B 11.85B 10.78B 20.31B 1,373B 20.46B 143B 55.7B 701B 53.52B 52.36B 2,253B 15.8B 14.09B 13.13B 11.95B 22.5B 1,521B 22.67B 159B 61.72B 776B 59.3B 58.02B 2,496B
Net Debt 31.4B 28.01B 26.1B 23.75B 44.73B 3,024B 45.06B 315B 123B 1,544B 118B 115B 4,961B 28.22B 25.17B 23.45B 21.34B 40.19B 2,718B 40.49B 283B 110B 1,387B 106B 104B 4,459B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
23
Last Close Price
140.29USD
Average target price
151.69USD
Spread / Average Target
+8.13%

Quarterly revenue - Rate of surprise